EUVIMEDEUVIMED entdecken
Open Access

Barriers to Isotretinoin Access and Treatment Continuity in an Underserved Pediatric Population: A Cross‐Sectional Study

Charles B Lau iD, Laxmi Behara, Susruthi Rajanala, Margaret Lee, Lisa Y Shen

Pediatric Dermatology · 2026

DOI: 10.1111/pde.70184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, 2026. Verfasst von Charles B Lau und 4 weiteren Autor:innen. Beteiligte Einrichtung: Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Isotretinoin, Health Services Accessibility, Dermatologic Agents, Acne Vulgaris. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Isotretinoin is a highly effective treatment for severe acne, but its use is often complicated by scheduling, pharmacy, and iPLEDGE‐related barriers that may contribute to greater administrative burden for patients facing pre‐existing structural barriers to care. We conducted a cross‐sectional survey study of 42 pediatric patients at an urban safety‐net hospital who had completed at least 1 month of isotretinoin, assessing demographics, treatment experience, and barriers to use. Overall, 64.3% of patients reported appointment, pharmacy, or financial‐related difficulties, contributing to treatment gaps in 33.3%; nevertheless, 97.6% felt their treatment was successful. Despite high perceived efficacy, isotretinoin use was impacted by administrative and iPLEDGE‐related requirements, potentially magnifying existing access barriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsotretinoinHealth Services AccessibilityDermatologic AgentsAcne VulgarisHumansCross-Sectional StudiesChildFemaleMaleAdolescent

Stichwörter der Autor:innen

acne vulgarishealth disparitiesiPLEDGEisotretinoinpediatric dermatologysafety‐net hospitalteledermatology

Substanzen

IsotretinoinDermatologic Agents

Autor:innen und Institutionen

  • Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
  • Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Dermatology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.

ORCID-Profile: Charles B Lau

Zitieren

APA

Lau, C. B., Behara, L., Rajanala, S., Lee, M., & Shen, L. Y. (2026). Barriers to Isotretinoin Access and Treatment Continuity in an Underserved Pediatric Population: A Cross‐Sectional Study. Pediatric Dermatology. https://doi.org/10.1111/pde.70184

Vancouver

Lau CB, Behara L, Rajanala S, Lee M, Shen LY. Barriers to Isotretinoin Access and Treatment Continuity in an Underserved Pediatric Population: A Cross‐Sectional Study. Pediatric Dermatology. 2026. doi:10.1111/pde.70184

BibTeX
@article{Lau2026,
  author = {Lau, Charles B and Behara, Laxmi and Rajanala, Susruthi and Lee, Margaret and Shen, Lisa Y},
  title = {Barriers to Isotretinoin Access and Treatment Continuity in an Underserved Pediatric Population: A Cross‐Sectional Study},
  journal = {Pediatric Dermatology},
  year = {2026},
  doi = {10.1111/pde.70184}
}
Kostenlos starten →